Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects
Krieckaert, C L M, Nair, S C, Nurmohamed, M T, van Dongen, C J J, Lems, W F, Lafeber, F P J G, Bijlsma, J W J, Koffijberg, H, Wolbink, G, Welsing, P M JVolume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-204101
Date:
February, 2015
File:
PDF, 1.43 MB
english, 2015